ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 303K)  | Related Articles | Citation Tracking

Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients
H. S. MERKI 1 , L. WITZEL 1 , R. P. WALT*, J. NEUMANN 1 , E. SCHEURLE 1 , D. KAUFMANN 1 , A. MAPPES 1 , J. HEIM 1 J. RÖHMEL
  1 DRK Hospital Mark Brandenburg, Department of Gastroenterology, Berlin, Federal Republic of Germany   *Department of Therapeutics, Queen's Medical Centre, Nottingham United Kingdom   Department of Statistics, Arzneimittelforschung Berlin (AFB), Berlin, Federal Republic of Germany
 Correspondence: Dr H. S. Merki, DRK Hospital Mark Brandenburg, Drontheimerstrasse 39, D-1000 Berlin 65, West Germany (FRG).
Copyright 1987 Blackwell Scientific Publications Ltd.

ABSTRACT

AbstractREFERENCES

Continuous measurement of 24-hour intragastric acidity was performed in 12 duodenal ulcer patients in remission during treatment with placebo, ranitidine 300 mg nocte and ranitidine 300 mg b.d. Median 24-hour acidity was 79.4 mmol litre−1 during placebo treatment; it decreased to 28.2 mmol litre−1 during treatment with ranitidine 300 mg nocte and to 3.6 mmol litre−1 during treatment with ranitidine 300 mg b.d. The two regimens decreased intragastric acidity to a similar degree during the night, but significantly greater inhibition of daytime and 24-hour acidity followed use of ranitidine 300 mg b.d.


Accepted for publication 20 February 1987

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2036.1987.tb00621.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Click here
Sign Up Now
Wiley Medical Twitter